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Background: Peripheral neuropathy (PN) is a common neurological complication in patients with diabe-
tes mellitus (DM) which affects their quality of life.
Objective: To determine the frequency of PN and the risk factors associated with its occurrence in the
studied diabetic patients.
Subjects and methods: A cross sectional study was conducted in Al-Azhar University Hospitals, Cairo,
Egypt. The study recruited 300 patients with type-II DM who attending the outpatient diabetic clinics
in the studied hospitals, from October 1st 2005 through January 2006. A clinical neurological examination
was conducted for all patients using the Michigan Neuropathy Diabetic Scoring (MNDS) criteria for diag-
nosis of PN. Subsequently, we considered patients with PN as study cases, and those without PN as con-
trols to assess the risk factors associated with PN. Statistical analysis including multivariate logistic
regression analysis was done.
Results: The frequency of PN among the studied subjects was 29.7%. Related risk factors were: older age
above 60 years (odds ratio (OR) = 73.0; 95% conﬁdence interval (CI) = 14.2–377.2), associated moderate to
severe hypertension (OR = 10.2; 95% CI = 2.8–38.0) and associated ischemic heart disease (IHD)
(OR = 3.80; 95% CI = 1.50–9.80), poor control of DM (OR = 9.1; 95% CI = 2.6–32.1), and duration of DM.
The risk of PN, however, was signiﬁcantly reduced among married patients and those reported high edu-
cational and family income levels.
Conclusions: Diabetic PN is a considerable complication of DM. The related risk factors were old age, pro-
longed and poorly controlled DM and associated medical disorders.
 2009 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
Diabetes mellitus (DM) is one of the most widespread chronic
diseases in the world. Nearly 10% of Egyptian people are affected
by DM type-II in 2000 and this ﬁgure is expected to increase to
13.3% in 2025 [1]. DM has two types of complications: microvascu-
lar and macrovascular. One of the most frequently-occurring
microvascular complications is diabetic neuropathy, of which the
most common type is distal symmetrical neuropathy or peripheral
neuropathy (PN) [2]. Complications of PN include severe pain, loss
of ambulation and increased risk of foot ulceration and amputation
[3].
Incidences of diabetic PN have been reported in 10–50% of
patients with diabetes mellitus in Western countries [3]. At the
time of diagnosis, PN is present in 10% of diabetic patients and
overall in 50% of patients with a 25-year history of the disease
[4]. The incidence of PN in diabetic children was 10% in a studyellitus. Published by Elsevier Ltd. Oconducted in Alexandria, Egypt, and included 20 children with
type-I diabetes mellitus [5]. Several epidemiological studies have
been proposed to explain the various risk factors inﬂuencing the
occurrence and progression of PN. The prevalence of PN is found
to be closely associated with high blood pressure (BP), hyperlipid-
emia and cigarette smoking [6]. Older age of diabetic patients,
duration of the disease and poor diabetic control were also found
to have a signiﬁcant role in the occurrence of PN [7,8].
Peripheral neuropathy is the ﬁrst step in the generation of dia-
betic foot ulcer. Foot ulcers develop in risk areas that are exact
pressure points. If not detected early, these lesions may progress
to gangrene and result in amputation [6]. It has been found that
the life-time risk of foot amputation to be 15% in patients with dia-
betic PN [9]. Identiﬁcation of the risk factors associated with PN is
important to decrease its occurrence, preventing the associated
secondary complications, and improving the quality of life for dia-
betic patients [9]. Since there is no regional evidence concerned
with this important diabetic complication, except that conducted
in Alexandria and which was only concerned with type-I DM in
children, this study aimed to explore the prevalence of PN amongpen access under CC BY-NC-ND license.
Table 1
Comparison of sociodemographic characteristics between the studied diabetic
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the occurrence of PN among them.patients with and without peripheral neuropathy (PN).
Characteristics Patients with
PN (cases)
Patients without
PN (controls)
P-value
No. % No. %
Age (years)
<50 16 18.0 178 84.4
50–60 44 49.4 31 14.6
>60 29 32.6 2 1.0 <.0001
Sex
Male 52 41.6 106 49.8
Female 37 58.4 105 50.2 0.19
Education
Illiterate 64 72.0 67 31.7
Less than secondary 4 5.0 87 41.3
Secondary and higher 21 23.0 57 27.0 <.0001
Occupation
Unskilled 58 65.0 139 66.0
Skilled 18 20.0 39 18.0
Employee 13 15.0 33 15.0 0.51
Marital status
Married 39 44.0 45 21.0
Un-married 50 56.0 166 79.0 <.0001
Family income
Low 65 73.0 118 56.0
Moderate 16 18.0 60 28.4
High 8 9.0 33 15.6 0.02
Table 2
Adjusted odds ratio (OR) and 95% conﬁdence interval (CI) for the association of
sociodemographic and lifestyle factors with peripheral neuropathy in the studied
diabetic patients.
Sociodemographic
and lifestyle factors
Patients
with
PN (cases)
Patients
without
PN (controls)
ORa 95% CI
Age (years)
<50 16 178 1.00 Ref.
50–60 44 31 12.9 5.9–12.0
>60 29 2 73.0 14.2–377.2
Sex
Female 37 105 1.00 Ref.
Male 52 106 1.40 0.85–2.30
Education
Illiterate 64 67 1.00 Ref.
Less than secondary 21 87 0.25 0.14–0.45
Secondary and higher 4 57 0.10 0.03–0.21
Occupation
Unskilled 58 139 1.00 Ref.
Skilled 13 39 0.80 0.40–1.60
Professional 18 33 1.30 0.70–2.50
Marital status
Un-married 39 45 1.00 Ref.
Married 50 166 0.35 0.20–0.60
Family income per month2. Patients and methods
In this cross sectional study, we recruited 300 diabetic patients
from the diabetic outpatient clinics at Al-Azhar University Hospi-
tals. In this study, we calculated the prevalence of peripheral neu-
ropathy (PN). We also used a nested case-control approach to
examine the risk factors associated with PN among the studied
patients. Patients with PN were considered as the study cases
and those without PN were considered as controls. During recruit-
ment, we excluded patients with speciﬁc neurological disease,
such as stroke, loss of dorsalis pedis pulses and those with less than
one year duration of disease. We took a written consent from the
patients before they were enrolled in the study.
Diagnosis of PN to determine its prevalence among the studied
patients and to differentiate between the studied cases and con-
trols was performed, by using Michigan Neuropathy Diabetic Scor-
ing (MNDS) [10]. This system gives a score in the range 0–8, based
on evaluation of 4 different factors in each leg. These factors are:
appearance of foot (dry skin, callus, deformities, ﬁssure, and infec-
tion), presence of ulcer, vibration perception in the great toe (mea-
sured with a 128 Hz tuning fork), and Achilles tendon reﬂex. The
components were given a score of 0.5 or 1 on the basis of the rel-
evant signs. This scoring system has a sensitivity and speciﬁcity of
nearly 95%. A neuropathic foot usually scores 3 or higher, a normal
foot 2.5 or lower [11].
Detailed information was collected on each patient’s age, sex,
education, occupation, family income, marital status, height,
weight, smoking status, duration of diabetes mellitus, degree of
blood glucose control (poor, fair, good), presence of hypertension
and ischemic heart disease (IHD), and family history of DM. The
quality of diabetes control was classiﬁed as Good control if fasting
blood glucose (FBG) < 110 mg/dl, fair control if FBGP 110 and
<130 mg/dl, and poor control if FBGP 140 mg/dl. Seated blood
pressure was measured in the right arm, to the nearest 2 mm Hg
with a random zero sphygmomanometer and the mean of two
readings [for both systolic blood pressure (SBP), and the diastolic
blood pressure (DBP)] was recorded. Hypertensive patients were
identiﬁed according to the sixth report of the Joint National Com-
mittee on prevention, detection, evaluation and treatment of high
blood pressure [12], ischemic heart disease (IHD) was diagnosed by
history and electrocardiographic abnormalities [13], and fasting
blood sugar (FBS) by the glucose oxidase method (Pars Azmoon
kit).
The collected data were analyzed by using the software package
(SAS). In order to compare the distribution of demographic and
other studied factors of the studied patients, we used v2 tests for
the categorical variables and t test for the continuous variables.
We also used multivariate logistic regression models to estimate
odds ratios and their 95% conﬁdence intervals for the association
of PN with the studied variables [14], while controlling for the pos-
sible covariates.Low 65 118 1.00 Ref.
Moderate 16 60 0.50 0.26–100
High 8 33 0.45 0.20–0.98
Smoking status
Never 51 161 1.00 Ref.
Ex-smoker 19 5 2.00 0.50–8.50
Current smoker 19 45 0.98 0.43–2.21
Body mass index (BMI)
<25 60 123 1.00 Ref.
25 to <30 26 61 1.50 0.71–3.30
P30 3 27 0.40 0.10–1.50
a OR of each studied variable is adjusted by other ones included in this table.3. Results
Of the 300 diabetic patients, there were 89 (29.7%) patients
diagnosed as having diabetic peripheral neuropathy (PN). The
mean age of all the studied subjects was 48.1 ± 11.3 (18–75 years),
and the average duration of disease was 8.2 ± 4.9 years. The male
patients were 158 (52.7%) and the female patients were 142
(47.3%). Table 1 compares the sociodemographic characteristics
among cases and controls. With the exception of sex distribution
and occupation, there have been statistically signiﬁcantly differ-
Table 3
Adjusted odds ratio (OR) and 95% conﬁdence interval (CI) for the association of
diabetes mellitus related factors and associated medical disorders with peripheral
neuropathy in the studied diabetic patients.
Studied factors Patients with
PN (cases)
Patients without
PN (controls)
ORa 95% CI
Duration of diabetes
<5 years 8 69 1.00 Ref.
5–10 years 32 115 3.10 1.22–9.40
>10 years 49 27 6.20 2.10–18.8
Diabetic controlb
Good 40 162 1.00 Ref.
Fair 29 43 1.60 0.66–3.35
Poor 20 6 9.10 2.60–32.1
Associated hypertension
Normotensive 27 167 1.00 Ref.
Mild hypertension 32 40 1.25 0.55–2.78
Moderate to severe 30 4 10.2 2.75–38.0
Associated IHD
No 55 195 1.00 Ref.
Yes 34 16 3.80 1.50–9.80
Family history of DM
No 48 174 1.00 Ref.
Yes 41 37 4.01 1.20–8.90
a OR is adjusted by age and educational levels.
b Good control if fasting blood glucose (FBG) < 110 mg/dl, fair control if
FBGP 110 and <130 mg/dl, and poor control if FBGP 140 mg/dl.
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odemographic variables. Cases were mostly older. The percentage
of married cases, and those reporting positive family history of
DM, was higher when compared to controls. Also, the percentage
of cases in the lowest family income level was higher compared
to controls.
Table 2 presents the association between PN and the studied
sociodemographic factors. The most important factor associated
with PN was the age of patients. Compared with patients aged less
than 50 years, the adjusted ORs were 12.9 (5.9–12.0), and 73.0
(95% = 14.2–377.2) for patients aged greater than 60 years. The risk
of PN is also increased 1.4 fold among male patients, although
insigniﬁcant (OR = 1.40, 95% CI = 0.85–2.30). On the other hand,
we found that increasing educational level and family income sig-
niﬁcantly reduced the risk. Similarly, the risk was reduced among
married and obese patients. Compared to never smokers, no risk
of PN was observed among current smokers while the risk was
about two times among the ex-smokers, although insigniﬁcant
(OR = 2.0; 95% = 0.50–8.50).
Table 3 shows the adjusted OR and their 95% conﬁdence inter-
vals for the association of PN with DM related factors and associ-
ated medical disorders. The results indicate that the longer the
duration of DM, the higher the risk of PN. The risk is found to be
three times higher among patients reporting a history of DM rang-
ing from 5–10 years and to be six times more among patients with
DM of more than 10 years. Poor diabetic control increases the risk
of PN by about nine times (OR = 9.10; 95% CI = 2.60–32.1). Also, we
found that, the associated severe hypertension and IHD increased
the risk of PN; where the adjusted ORs were 10.2 (95% = 2.75–
38.0) and 3.80 (95% CI = 1.50–9.80), respectively. The patients re-
ported positive family history of DM were found to have four times
the risk to developing PN, as compared with those without a family
history of DM.4. Discussion
Peripheral neuropathy is a common complication of DM, with
impairment of quality of life and high morbidity. This hospital-
based study found a considerable prevalence of PN among diabeticpatients (29.7%). We also found several (?) factors which are signif-
icantly associated with an increased risk of PN. These factors in-
clude older age, duration of diabetes, poor control of diabetes
and associated hypertension and ischemic heart diseases. The
highest risk was among those older patients above 60 years
(OR = 73.0; 95% CI = 14.2–377.2). We also found that other factors
to decrease the risk of PN among the studied patients. These factors
include marriage and high educational and family income levels.
The prevalence of PN observed in this study was similar to that
reported in a previous large study, including 3250 diabetic pa-
tients, where the prevalence of PN was about 28% among them
[15]. The results of our study also conﬁrm previous reports regard-
ing the association of PN with old age, duration of disease and poor
diabetic control. Consistent with our study results, the previous
studies have also shown associations of PN with old age [1,8], dura-
tion of disease [1,16] and poor diabetic control [17,18].
Cigarette smoking was found to be associated with an increased
risk of PN in some of the previous studies [8,19]. In our study, how-
ever, no relationship was found between PN and current smoking,
although ex-smokers are found to have double the risk when com-
pared to never smokers. This observed difference might be ex-
plained by the ﬁnding that more healthy smokers continued
smoking, while the less healthy stopped [20]. Our study results
conﬁrm this ﬁnding, as we actually found the risk to increase
among ex-smokers.
The observed protective effect of marriage, increasing educa-
tional level and high family income appeared to be consistent with
the results of studies that link better health care and self care
knowledge and practice with higher educational and family in-
come levels [21,22]. Moreover, marriage may buffer against stress
and thereby reduce the activation of neuroendocrine system,
which may lead to a reduction in atherosclerosis and other patho-
logical processes [23]. The protective effect of obesity on the risk of
PN observed in this study may be explained by the ﬁndings re-
ported in some studies [18], namely that PN is more common
among tall patients. Obese subjects tend to be shorter and in our
study, the mean height of obese individuals was relatively lower,
when compared with normal and overweight patients with signif-
icant difference. Moreover, most obese cases were females (5.5%)
compared to obese male cases (2.0%), with signiﬁcant difference.
Our study found the risk of PN to be associated with males and
the risk is about 1.5 folds more than in females.
Although this study included a relatively large number of vari-
ables, it did not take into consideration some of the important lab-
oratory parameters such as; serum lipids and cholesterol, and the
average glycosylated hemoglobin (HbA1C) that quantify the quality
of diabetic control better than the FBG used in this study. These
parameters are not included because of their high cost and the
low resources available for the study.
The diagnosis of PN among diabetic patients in this study was
based only on the Michigan Neuropathy Diabetic Scoring (MNDS)
criteria. However, our data results are concordant with the Diabe-
tes Control and Complications Trial (DCCT) [24] and the United
Kingdom Prospective Diabetes Study (UKPDS) [25] results, which
used nerve conduction (EMG-NCV) to identify neuropathic pa-
tients. Therefore, it can be concluded that MNDS criteria can be
used with high conﬁdence as an outpatient screening method.
In conclusion, this study found that PN is highly prevalent
among diabetic patients attending hospital outpatient clinics in
Egypt. Although the associated risk factors observed in this study
were consistent with other previous studies, the generalization of
these results to general population is questionable, because of
the hospital-based data used in this and most of the previous stud-
ies. To conﬁrm these results, further studies with community-
based data are needed, which take into consideration the effect
of factors not included in this study on the risk of PN.
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